Society guideline links: Chronic kidney disease in adults

Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

Links to related guidelines are provided separately.

●(See "Society guideline links: Chronic kidney disease in children".)

●(See "Society guideline links: Chronic kidney disease-mineral and bone disorder".)

●(See "Society guideline links: Anemia in chronic kidney disease".)

●(See "Society guideline links: Dialysis".)

●(See "Society guideline links: Diabetic kidney disease".)

International

●Kidney Disease: Improving Global Outcomes (KDIGO): Clinical practice guideline on the management of blood pressure in chronic kidney disease (2021)

●International Society of Renal Nutrition and Metabolism (ISRNM): Consensus statement for the etiology of the protein-energy wasting syndrome in chronic kidney disease (2013)

●ISRNM: Consensus statement for the prevention and treatment of protein energy wasting in chronic kidney disease patients (2013)

●KDIGO: Clinical practice guideline for lipid management in chronic kidney disease (2013)

●KDIGO: Clinical practice guideline for the evaluation and management of chronic kidney disease, 2012 (published 2013)

●International Society of Nephrology (ISN) and International Pediatric Nephrology Association (IPNA): Consensus statement for the transition from pediatric to adult renal services (2011)

Canada

●Choosing Wisely Canada: Don't initiate dialysis in outpatients with Stage 5 CKD in the absence of clinical indications (2021)

●Choosing Wisely Canada: Don't prescribe nonsteroidal anti-inflammatory drugs (NSAIDs) in individuals with hypertension or heart failure or CKD of all causes, including diabetes (2021)

●British Columbia Guidelines and Protocols and Advisory Committee (GPAC): Chronic kidney disease – Identification, evaluation and management of adult patients (2019)

United States

●National Kidney Foundation (NKF) and the American Society of Nephrology (ASN): A unifying approach for GFR estimation – Recommendations on reassessing the inclusion of race in diagnosing kidney disease (2021)

●American College of Radiology (ACR): ACR Appropriateness Criteria on renal failure (revised 2020)

●Kidney Disease Outcomes Quality Initiative (KDOQI): Clinical practice guideline for nutrition in CKD, update (2020)

●US Department of Veterans Affairs (VA)/Department of Defense (DoD): Clinical practice guideline for the management of chronic kidney disease (CKD) (2019)

●Centers for Disease Control and Prevention (CDC): Guidelines for vaccinating kidney dialysis patients and patients with chronic kidney disease (2012, reviewed 2015)

●Infectious Diseases Society of America (IDSA): Clinical practice guideline for the management of chronic kidney disease in patients infected with HIV, update (2014)

●KDOQI: Clinical practice guideline for diabetes and CKD, update (2012)

●American Society of Parenteral and Enteral Nutrition (ASPEN): Clinical guidelines on nutrition support in adult acute and chronic renal failure (2010)

Europe

●European Society for Clinical Nutrition and Metabolism (ESPEN): Guideline on clinical nutrition in hospitalized patients with acute or chronic kidney disease (2021)

●European Renal Best Practice (ERBP): Clinical practice guideline on management of older patients with chronic kidney disease stage 3b or higher (eGFR <45 mL/min/1.73 m2) (2016)

●ERBP: Clinical practice guideline on management of patients with diabetes and chronic kidney disease stage 3b or higher (eGFR <45 mL/min) (2015)

●ERBP: Position statement on the Kidney Disease: Improving Global Outcomes (KDIGO) clinical practice guideline for the management of blood pressure in non-dialysis-dependent chronic kidney disease – An endorsement with some caveats for real-life application (2013)

●ESPEN: Guidelines on parenteral nutrition – Adult renal failure (2009)

United Kingdom

●UK Kidney Association (UKKA): Clinical practice guideline on sodium-glucose co-transporter-2 (SGLT-2) inhibition in adults with kidney disease (2023)

●National Institute for Health and Care Excellence (NICE): Guideline on chronic kidney disease – Assessment and management (2021)

●The Renal Association (RA): Clinical practice guideline – Exercise and lifestyle in chronic kidney disease (2021)

●RA: Clinical practice guideline – Pregnancy and renal disease (2019)

●RA: Clinical practice guideline – Undernutrition in chronic kidney disease (2019)

●NICE: Quality standard on chronic kidney disease in adults (2011, updated 2017)

Australia–New Zealand

●Caring for Australasians with Renal Impairment (CARI): Chronic kidney disease guidelines

●Kidney Health Australia: Chronic kidney disease (CKD) management in general practice – Guidelines and clinical tips to help identify, manage and refer patients with CKD in your practice, 4th edition (2020, updated 2022)

●Palliative Care Australia (PCA) and Kidney Health Australia: Palliative care for chronic and end-stage kidney disease – Position statement (2018)

●New Zealand Ministry of Health: Managing chronic kidney disease in primary care – National consensus statement (2015)

●Exercise and Sports Science Australia (ESSA): Position statement on exercise and chronic kidney disease (2013)

●Royal Australian College of General Practitioners (RACGP): Chronic kidney disease in the elderly – Assessment and management (2012)

Japan

●[In Japanese] Japanese Society of Nephrology (JSN): Recommendations for proper use of SGLT2 inhibitors in CKD treatment (2022)

●[In English] Japanese Society of Renal Rehabilitation (JSRR): Clinical practice guideline for renal rehabilitation – Systematic reviews and recommendations of exercise therapies in patients with kidney diseases (2019)

●[In English] JSN: Essential points from evidence-based clinical practice guideline for chronic kidney disease, 2018 (published 2019)

●[In Japanese] JSN: Dietary recommendations for predialysis CKD with sarcopenia and frailty (2019)

●[In Japanese] JSN: Evidence-based clinical practice guideline for CKD (2018)

●[In Japanese] JSRR: Renal rehabilitation guidelines (2018)

●[In Japanese] JSN: Clinical practice guidelines for the management of pregnancy in kidney disease patients (2017)

●[In Japanese] JSN: Smooth transition to prevention of kidney damage progression and renal replacement therapy – CKD stage G3b-5 clinical practice guideline (2017)

●[In Japanese] JSN: Recommendations for reducing the number of new dialysis patients from lifestyle-related diseases – Prevention and early detection of CKD (chronic kidney disease) (2016)

●[In English] Asian Forum for Chronic Kidney Disease Initiative (AFCKDI): Asian chronic kidney disease best practice recommendations – Positional statements (2011)